Meeting
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
HER2 gene amplification and protein overexpression in uterine clear cell carcinoma and its implications in targeted immunotherapy.
Authors
Jain Zhou
Mayo Clinic, Rochester, MN
Jain Zhou, William R. Sukov, Jodi M Carter, J. Kenneth Schoolmeester
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Biomarkers and Inflammatory Signatures,Humoral Immunity for Diagnosis and Therapy,Immune Checkpoints and Stimulatory Receptors,Modulating Innate Immunity,Therapies Targeting T cells
Sub Track
Novel Biomarker Approaches
Citation
J Clin Oncol 35, 2017 (suppl 7S; abstract 29)
DOI
10.1200/JCO.2017.35.7_suppl.29
Abstract #
29
Poster Bd #
D2
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.
First Author: Michael Alexander Gordon
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The HORIZON III retrospective exploratory analysis: HER2 expression amplification in colorectal cancer.
First Author: Fabiola Cecchi
Poster
2015 ASCO Annual Meeting
Defining the spectrum and "overlap" of HER2 aberrations in lung cancers: Associations of HER2 protein overexpression, HER2 amplification, and HER2 mutation.
First Author: Bob T. Li
Poster
2014 Gastrointestinal Cancers Symposium
A novel method combining gene and protein platforms on one slide for the detection of HER2 in gastric cancer: Final results.
First Author: Dominique Werner